Saturday 17 October 2026 Export BBIO’s income statement to Excel — free account

BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $502.1 million, up 126.3% from fiscal 2024. In the quarter to June 2026, revenue grew 120.4%, EPS grew 17.9%, free cash flow grew 16.6% and total debt rose 4.22%, each against the same quarter a year earlier.

66.39 0.74 −1.10%

Follow BBIO

Alert me

Market cap: $13.1B
P/E: 0.0×
Fwd P/E: −31.1×
Dividend yield: —
F-score: 3/9
Altman Z: −3.45
Beneish M: 8.17
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	4	3	4	4
ROE Full definition →		50.74%	41.03%	36.94%	32.31%
ROA Full definition →		(95.85%)	(78.14%)	(64.06%)	(60.23%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(126.81%)	(140.72%)	(167.85%)	(333.08%)
Average Days of Receivables Full definition →		120.21	101.37	129.16	130.26
Free Cash Flow per Share Full definition →		(3.12)	(2.38)	(2.29)	(2.22)
Free Cash Flow Full definition →		(597.75)	(455.55)	(445.12)	(435.39)
Capital Expenditures Full definition →		(12.93)	(9.64)	(1.17)	(1.01)
Other line items
Cash ROIC Full definition →		(104.10%)	(125.17%)	(74.39%)	(304.86%)
Accounts Receivable Turnover Full definition →		6.05	6.97	3.62	4.30
Accounts Payable Turnover Full definition →		0.93	0.91	1.00	1.49
Inventory Turnover Full definition →		0.00	0.00	1.53	1.12
Average Days of Payables Full definition →		456.94	630.82	375.28	250.38
Days of Inventory on Hand Full definition →		599.26	465.84	425.93	486.38
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		131.69%	90.02%	80.55%	70.87%
Selling, General and Administrative Expense of Revenue Full definition →		132.26%	105.81%	101.52%	90.58%
Share Based Compensation of Revenue Full definition →		36.33%	26.49%	24.21%	20.65%
Interest Coverage Full definition →		(3.87)	(2.94)	(2.78)	(2.42)
Operating CF/Net income Full definition →		0.73	0.62	0.62	0.63
Depreciation/Fixed assets Full definition →		2.20	2.12	2.33	2.24
Capex/Depreciation Full definition →		(1.01)	(0.85)	(0.10)	(0.09)
Revenue per Share Full definition →		1.84	2.62	2.98	3.64
Operating CF per Share Full definition →		(3.05)	(2.33)	(2.28)	(2.22)
Capex per Share Full definition →		(0.07)	(0.05)	(0.01)	(0.01)
Capex to Sales Full definition →		0.04	0.02	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly